NCT05819892 2026-05-20Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial CancerM.D. Anderson Cancer CenterPhase 1 Recruiting21 enrolled